Compare COEP & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COEP | CRT |
|---|---|---|
| Founded | 2017 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 42.5M |
| IPO Year | N/A | 1992 |
| Metric | COEP | CRT |
|---|---|---|
| Price | $16.20 | $8.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 69.6K | 36.9K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | $500,996.00 | ★ $5,621,913.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.49 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.31 | $7.07 |
| 52 Week High | $21.41 | $13.31 |
| Indicator | COEP | CRT |
|---|---|---|
| Relative Strength Index (RSI) | 51.88 | 56.25 |
| Support Level | $15.40 | $8.29 |
| Resistance Level | $16.80 | $8.69 |
| Average True Range (ATR) | 1.53 | 0.20 |
| MACD | -0.07 | -0.06 |
| Stochastic Oscillator | 30.02 | 41.93 |
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.